"Miracle drugs" and a "humanity free of infectious diseases" owing to their use are catch phrases now relegated to the recent past. In the last 10 years there has been reported a rising percentage of bacterial isolates from clinical sources, resistant to one or more antibiotics formerly effective in eradicating them. These reports have come from several European countries and from all sections of the United States. Micrococcus pyogenes, foremost, by far, of the microorganisms displaying increased resistance, is a familiar enemy, with which many recent publications have dealt. No attempt will be made to review those numerous publications here, a considerable task which has been well done recently by McCoy.1 The addition of a new publication to an already voluminous literature on the subject requires some justification. This is supplied by the fact that the sudden outbreak of staphylcoccal pneumonia, terminating fatally in some instances, at our hospital
KETCHAM AS, BRANCATO FP. Outbreak of Postoperative Micrococcal Pneumonia: A Clinical Analysis with Bacteriological Data. AMA Arch Surg. 1956;73(6):965–969. doi:10.1001/archsurg.1956.01280060065014
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: